Founded in 2015 with the pursuit “serving society, health world”focusing on the R&D , production , development , sales and service of In Vitro diagnostic products and veterinary products.
Creating and mastering core innovative technologies for raw materials and relying on years of continuous R&D investment and reasonable layout, testsea has built immunological detection platform, molecular biology detection platform, protein core sheet inspection platform , and biological raw material
Based on the above technology platforms, Testsea has developed the product lines to the rapid identification of corona virus disease, cardiovascular diseases, inflammation, tumor, infectious diseases, drug abuse, pregnancy, etc. Our products are widely used in the rapid diagnosis and effective treatment monitoring of critical and severe diseases, maternal and children healthcare drug detection, alcohol testing, and other fields and sales have covered more than 100 countries and regions across the world .
A biomedical technology enterprise focusing on medical in vitro diagnostic products.
Cooperative 
Completed Production R&D SystemThe company now has a complete set of R & D, production equipment and purification
workshop for in vitro diagnostic instruments I reagents I raw materials for POCT, biochemistry,immunity and molecular diagnosis
Annual Production Capacity
In 2015, hangzhou testsea biotechnology co.,ltd was established by the founder of company with expert team from Chinese Academy of Sciences and Zhejiang University.
In 2019 , setting up a foreign trade sales team to develop overseas markets
A big Action
After several years of technical development, launch a variety of competitive products, such as Veterinary rapid test kits test kits , Swin fever detection test .
With the outbreak of the corona virus epidemic at the end of 2019, our company and academician of the Chinese Academy of Sciences rapidly developed and launched COVID-19 Test，and obtain free sale certification and many countries approval, speed up the COVID-19 Control.
TESTSEALABS COVID-19 antigen test products obtained EU CE certification, German PEI&BfArm List, Australia TGA, UK MHRA, Thailand FDA, ect
Move to New factory-56000㎡
In order to satisfy company’s increasing production capacity needs, new factories with 56000㎡ was completed, then annual production capacity has increased hundreds of times.
Team efficient cooperation , achieve first 1 billion sales value.
With stronger team cooperation capacity and relentless efforts , Testsea has already got more than 50 authorized patents, 30+registered in overseas countries.
With the vision of “Serving Society, Healthy World”, we are committed to contribute to human health by providing quality diagnostic products and promoting the accurate diagnosis of diseases for all human beings.
“Integrity, quality and responsibility” is the philosophy we are pursuing, and Testsea strives to develop into an innovative, caring company that respects society and the environment, makes its employees proud and gains the long-term trust of its partner.
Prompt, fast, sensitive and accurate, Testsea Biologicals is here to help you with your diagnostic testing.
Testsea is challenging new technology development with innovative efforts to realize all possibilities. We are constantly researching and developing products that are more effective, with free and creative thinking, and a fast and flexible organizational culture to accommodate them.
Innovative products from Testsea start with a struggle to make people’s lives healthier and more enriching. People in many countries are concerned about what products they need most and are committed to product development that will benefit their lives.
Testsea has a social responsibility to make high quality products that enable people and animals to live a healthy life through early diagnosis. We will continue to devote ourselves through continuous efforts to give stable returns to investors.